हिंदी में पढ़ें

Bombay Stock Exchange (BSE)

Coronavirus impact on investor wealth: Rs 19.49 lakh cr wiped out in 4 days of share market mayhem

Coronavirus impact on investor wealth: Rs 19.49 lakh cr wiped out in 4 days of share market mayhem

Fri, Mar 20, 2020

Investors continued to suffer on Thursday, taking a hit of Rs 19.49 lakh crore in four days, as markets continued to reel under the threat of coronavirus and its impact on the overall economy.

Manic market selloff: Sensex, Nifty plummet over 10 pct; trading halts for 45 mins

Manic market selloff: Sensex, Nifty plummet over 10 pct; trading halts for 45 mins

Fri, Mar 13, 2020

Equity benchmark Sensex plummeted over 3,200 points and the broader Nifty sank near 8,600 level, hitting their lower circuit limits, in opening session on Friday as coronavirus pandemic-led recession fears

Share market: Sensex tanks over 1,100 points, Nifty 335 over Coronavirus fears

Share market: Sensex tanks over 1,100 points, Nifty 335 over Coronavirus fears

Fri, Feb 28, 2020

Share market fell with the Sensex falling 1,100 points as coronavirus fears deepened. The BSE Sensex was trading at 38,597.53, lower by 1,148.13 points or 2.89 per cent and National Stock Exchange was trading at 11,297.45, lower by 335.85 points or 2.89 per cent from its previous close.

TRENDING NOW

Share market today: Sensex drops over 200 pts; Nifty near 11,600

Share market today: Sensex drops over 200 pts; Nifty near 11,600

Thu, Feb 27, 2020

Sensex dropped over 200 points in opening session on Thursday as incessant foreign fund outflow and coronavirus overhang weighed on global investor sentiment.

What are penny stocks and 5 reasons why you shouldn't buy them - Explained

What are penny stocks and 5 reasons why you shouldn't buy them - Explained

Fri, Feb 15, 2019

A penny stock generally trades at a very low price that is usually below Rs 10 on the exchanges due to very less demand, but due to certain events their share prices spike causing a frenzy in markets.

These factors to drive Sensex this week; check Inflation data, Q3 earnings and other key market drivers

These factors to drive Sensex this week; check Inflation data, Q3 earnings and other key market drivers

Sun, Jan 13, 2019

"The progress of Q3 results will dictate the trend for market . For the week ahead CPI and WPI are the key data to be watchful," said Vinod Nair, Head of Research, Geojit Financial Services.

Anil Singhvi’s Market Strategy December 26: Metals are negative due to Global cues; Buy OMCs on Dips

Anil Singhvi’s Market Strategy December 26: Metals are negative due to Global cues; Buy OMCs on Dips

Wed, Dec 26, 2018

At the stock markets, the Sensex at the Bombay Stock Exchange lost 271.92 points, or 0.76 per cent, to end at 35,470.15 on Monday, December 24, 2018.

Anil Singhvi’s Market Strategy December 24: Market is Neutral; Buy OMC’s on dips

Anil Singhvi’s Market Strategy December 24: Market is Neutral; Buy OMC’s on dips

Mon, Dec 24, 2018

Amid negative global, domestic institutional investors (DIIs), foreign institutional investors (FII), cautious sentiment and neutral future and option (F&O) cues, the short-term trend of Indian market will be neutral on December 24, 2018.

Anil Singhvi’s Market Strategy December 21: PSU Banks & Cement are in focus; OBC, Dr. Reddy’s & Chennai Petro are Stock of the Day

Anil Singhvi’s Market Strategy December 21: PSU Banks & Cement are in focus; OBC, Dr. Reddy’s & Chennai Petro are Stock of the Day

Fri, Dec 21, 2018

Amid negative global, neutral domestic institutional investors (DIIs), future and option (F&O), foreign institutional investors (FII) and cautious sentiments cues, the short-term trend of Indian market will be positive on December 21, 2018.

Anil Singhvi’s Market Strategy December 7: Market is Negative; Oil Companies are Positive, buy on a dip

Anil Singhvi’s Market Strategy December 7: Market is Negative; Oil Companies are Positive, buy on a dip

Fri, Dec 07, 2018

The 30-share BSE Sensex lost 572.28 points, or 1.59% to close at 35,312.13 while Nifty 50 was down by 181.75 points, or 1.69% and closed at 10,601.15. Similarly, Nifty Bank fell by 321.30 points, or 1.21% to close at 26,198.30.

Ahead of RBI policy announcement, Sensex falls over 200 pts, Nifty slips under 10,800

Ahead of RBI policy announcement, Sensex falls over 200 pts, Nifty slips under 10,800

Wed, Dec 05, 2018

Ahead of RBI key rate announcement following the review meet, BSE benchmark Sensex dropped over 200 points in early trade Wednesday. This follows heavy selloff in global equities after concerns over US-China trade war resurfaced.

ITC shares decline nearly 3% despite good Q2 show

ITC shares decline nearly 3% despite good Q2 show

Fri, Oct 26, 2018

ITC stock Friday fell by nearly 3 per cent even as the diversified group reported 11.92 per cent rise in standalone net profit for the quarter ended September 30, 2018.

NBFC stocks continue free fall, tank up to 18.5% on liquidity concerns

NBFC stocks continue free fall, tank up to 18.5% on liquidity concerns

Fri, Oct 19, 2018

NBFC stocks continued to slump, dropping up to 18.5 per cent Friday, on liquidity concerns even as the Reserve Bank announced more measures to increase liquidity flows to the non-banking financial companies.

IT stocks face selling pressure, tank up to 6% over tightening H-1B visa norms

IT stocks face selling pressure, tank up to 6% over tightening H-1B visa norms

Fri, Oct 19, 2018

IT stocks declined up to 6 per cent Friday due to concerns over tightening of H1-B visa norms. Shares of Infosys dropped 3.11 per cent, TCS fell by 0.55 per cent and Wipro softened by 0.29 per cent on the BSE.

Global cues, rupee dent equity indices; Sensex down over 400 points

Global cues, rupee dent equity indices; Sensex down over 400 points

Fri, Oct 19, 2018

Broadly negative Asian markets, along with a slightly weak rupee and a marginal rise in global crude oil prices dragged the key domestic equity indices in the red during Friday`s trade session.

Top 10 companies lose Rs 2,55,995 cr in m-cap; RIL worst hit

Top 10 companies lose Rs 2,55,995 cr in m-cap; RIL worst hit

Sun, Oct 07, 2018

From the top 10 pack, RIL's market capitalisation (m-cap) plummeted Rs 1,32,061.4 crore to Rs 6,65,441.16 crore.

Sensex cracks 350 points on profit-booking, weak global cues

Sensex cracks 350 points on profit-booking, weak global cues

Mon, Sep 17, 2018

The NSE Nifty index too dipped below the 11,500-mark by falling 111.80 points, or 0.97 per cent, at 11,403.40.

Rupee, oil, global cues to determine market trend: Experts

Rupee, oil, global cues to determine market trend: Experts

Sun, Sep 16, 2018

With the rupee plumbing new lows against the dollar, the government Friday announced an array of steps, including removal of withholding tax on Masala bonds, relaxation for FPIs, and curbs on non-essential imports, to contain the widening current account deficit and shore up the domestic currency.

SBI top gainer today, up by 2%; Can this be the reason for uptick?

SBI top gainer today, up by 2%; Can this be the reason for uptick?

Tue, Sep 11, 2018

SBI manages to jump high today in trading

GMR Infrastructure divests stake in four Indonesian firms

GMR Infrastructure divests stake in four Indonesian firms

Tue, Sep 04, 2018

Shares of GMR Infrastructure closed at Rs 20.25 a unit on the BSE, down by 4.03 per cent from previous close.

Amaravati development needs $2-4 tln investment: N Chandrababu Naidu

Amaravati development needs $2-4 tln investment: N Chandrababu Naidu

Tue, Aug 28, 2018

It can be noted that the Andhra Pradesh government early this month had raised Rs 2,000 crore by way of issuance of 'Amaravati Bond 2018', which witnessed a record 1.53 times oversubscription.

Google-Paytm to buy Future Retail stake? Shares jump over 5 per cent over

Google-Paytm to buy Future Retail stake? Shares jump over 5 per cent over

Mon, Aug 27, 2018

At NSE, shares of the company gained 4.51 per cent to close at Rs 543.15

Abbott India targets both 'now' and 'next' therapies

Abbott India targets both 'now' and 'next' therapies

Mon, Aug 27, 2018

“Abbott plans to launch around 100 products over the next five years. Our focus remains on growing existing therapy areas such as gastroenterology, metabolics, vaccines, central nervous system and women’s health,” the company’s managing director Ambati Venu said.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x